AR091349A1 - Formulacion oral - Google Patents
Formulacion oralInfo
- Publication number
- AR091349A1 AR091349A1 ARP130101449A AR091349A1 AR 091349 A1 AR091349 A1 AR 091349A1 AR P130101449 A ARP130101449 A AR P130101449A AR 091349 A1 AR091349 A1 AR 091349A1
- Authority
- AR
- Argentina
- Prior art keywords
- oral formulation
- medicament
- pululane
- maltodextrin
- salts
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000003814 drug Substances 0.000 abstract 4
- 229920002774 Maltodextrin Polymers 0.000 abstract 2
- 239000005913 Maltodextrin Substances 0.000 abstract 2
- 239000003349 gelling agent Substances 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 229940035034 maltodextrin Drugs 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 244000215068 Acacia senegal Species 0.000 abstract 1
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 240000007472 Leucaena leucocephala Species 0.000 abstract 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000000205 acacia gum Substances 0.000 abstract 1
- 229960004372 aripiprazole Drugs 0.000 abstract 1
- ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical group C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 abstract 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261640474P | 2012-04-30 | 2012-04-30 | |
| US201361783163P | 2013-03-14 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR091349A1 true AR091349A1 (es) | 2015-01-28 |
Family
ID=48483123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101449 AR091349A1 (es) | 2012-04-30 | 2013-04-29 | Formulacion oral |
Country Status (21)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109498556A (zh) * | 2017-09-15 | 2019-03-22 | 万特制药(海南)有限公司 | 阿立哌唑口服溶液及其制备方法 |
| WO2022176017A1 (ja) * | 2021-02-16 | 2022-08-25 | 大塚製薬株式会社 | 非晶質体及び当該非晶質体を含む組成物 |
| US11654108B1 (en) | 2022-05-02 | 2023-05-23 | Medicated Chews, Llc | Sennoside medicated chews |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517886B1 (en) * | 1997-06-24 | 2003-02-11 | Biovail Corporation International | Positive hydration method of preparing confectionery and the resulting product |
| AUPQ970300A0 (en) * | 2000-08-29 | 2000-09-21 | Massa Nominees Pty Ltd | Advanced wireless network |
| FR2822644B1 (fr) * | 2001-03-30 | 2005-03-11 | Roquette Freres | Confiserie sans sucre |
| JP2004099558A (ja) * | 2002-09-11 | 2004-04-02 | Medorekkusu:Kk | 医薬用ゼリー組成物 |
| JP4547994B2 (ja) * | 2004-06-02 | 2010-09-22 | 救急薬品工業株式会社 | 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤 |
| JP4315393B2 (ja) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| WO2008050847A1 (en) * | 2006-10-25 | 2008-05-02 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| AU2008237246B2 (en) * | 2007-04-05 | 2014-06-05 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
| GB0818472D0 (en) * | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| WO2010116385A2 (en) * | 2009-04-08 | 2010-10-14 | Rubicon Research Private Limited | Pharmaceutical compositions for alleviating unpleasant taste |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
| US20110139164A1 (en) * | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| JP5611672B2 (ja) * | 2010-05-28 | 2014-10-22 | ゼリア新薬工業株式会社 | 経口ゼリー剤 |
| AR082494A1 (es) * | 2010-08-24 | 2012-12-12 | Otsuka Pharma Co Ltd | Composicion en torta y en suspension con contenido de derivado de carbostirilo y derivado de aceite de silicona y/o aceite de silicona |
| GB201016900D0 (en) * | 2010-10-06 | 2010-11-17 | Probio Asa | Emulsion |
| WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
-
2013
- 2013-04-29 AR ARP130101449 patent/AR091349A1/es unknown
- 2013-04-29 TW TW102115265A patent/TWI594765B/zh not_active IP Right Cessation
- 2013-04-30 MX MX2014013155A patent/MX2014013155A/es unknown
- 2013-04-30 WO PCT/JP2013/062985 patent/WO2013165021A1/en not_active Ceased
- 2013-04-30 EA EA201491995A patent/EA026187B1/ru not_active IP Right Cessation
- 2013-04-30 US US14/397,683 patent/US20150126521A1/en not_active Abandoned
- 2013-04-30 CN CN201380022960.1A patent/CN104271120A/zh active Pending
- 2013-04-30 HK HK15107872.1A patent/HK1207290A1/xx unknown
- 2013-04-30 EP EP13724634.4A patent/EP2844232A1/en not_active Withdrawn
- 2013-04-30 CA CA 2872004 patent/CA2872004A1/en not_active Abandoned
- 2013-04-30 IN IN9091DEN2014 patent/IN2014DN09091A/en unknown
- 2013-04-30 SG SG11201406261QA patent/SG11201406261QA/en unknown
- 2013-04-30 AU AU2013255256A patent/AU2013255256B2/en not_active Ceased
- 2013-04-30 KR KR1020147033472A patent/KR20150003898A/ko not_active Withdrawn
- 2013-04-30 JP JP2014553002A patent/JP6360795B2/ja active Active
- 2013-04-30 BR BR112014026879A patent/BR112014026879A2/pt not_active IP Right Cessation
- 2013-04-30 SG SG10201608954UA patent/SG10201608954UA/en unknown
- 2013-04-30 NZ NZ630029A patent/NZ630029A/en not_active IP Right Cessation
-
2014
- 2014-10-17 PH PH12014502323A patent/PH12014502323A1/en unknown
- 2014-10-19 IL IL235111A patent/IL235111A0/en unknown
- 2014-11-06 ZA ZA2014/08114A patent/ZA201408114B/en unknown
- 2014-11-26 CO CO14260294A patent/CO7151505A2/es unknown
-
2017
- 2017-04-05 US US15/479,409 patent/US20170202833A1/en not_active Abandoned
- 2017-10-27 US US15/795,500 patent/US20180055840A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL235111A0 (en) | 2014-12-31 |
| IN2014DN09091A (cg-RX-API-DMAC7.html) | 2015-05-22 |
| CO7151505A2 (es) | 2014-12-29 |
| ZA201408114B (en) | 2016-08-31 |
| CA2872004A1 (en) | 2013-11-07 |
| PH12014502323A1 (en) | 2015-01-12 |
| JP2015515959A (ja) | 2015-06-04 |
| EP2844232A1 (en) | 2015-03-11 |
| HK1207290A1 (en) | 2016-01-29 |
| WO2013165021A1 (en) | 2013-11-07 |
| MX2014013155A (es) | 2015-05-08 |
| NZ630029A (en) | 2016-05-27 |
| SG10201608954UA (en) | 2016-12-29 |
| EA026187B1 (ru) | 2017-03-31 |
| TW201347773A (zh) | 2013-12-01 |
| SG11201406261QA (en) | 2014-11-27 |
| US20150126521A1 (en) | 2015-05-07 |
| JP6360795B2 (ja) | 2018-07-18 |
| KR20150003898A (ko) | 2015-01-09 |
| AU2013255256A2 (en) | 2014-11-13 |
| TWI594765B (zh) | 2017-08-11 |
| AU2013255256A1 (en) | 2014-10-30 |
| US20170202833A1 (en) | 2017-07-20 |
| CN104271120A (zh) | 2015-01-07 |
| EA201491995A1 (ru) | 2015-02-27 |
| US20180055840A1 (en) | 2018-03-01 |
| AU2013255256B2 (en) | 2017-09-07 |
| BR112014026879A2 (pt) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015002117A (es) | Metodo y sistema para dispensar una composicion. | |
| CL2015003442A1 (es) | Derivados heterociclicos | |
| UY34617A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas | |
| MX2021010033A (es) | Composiciones microencapsuladas de cannabinoides. | |
| MX2019012979A (es) | Composiciones para el cuidado bucal. | |
| DOP2016000253A (es) | Nuevos compuestos | |
| BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
| CL2016000143A1 (es) | Comprimido farmacéutico que comprende ácido acetilsalicílico y clopidogrel | |
| CL2014002282A1 (es) | Anticuerpos contra la metaloproteinasa de la matriz 9 (mmp9 gelatinasa b); composicion farmaceutica que la contiene; y sus usos. | |
| MX376628B (es) | Composiciones para el cuidado bucal. | |
| CL2014002975A1 (es) | Método in vitro para el diagnostico y vigilancia del cáncer, que comprende determinar la razón entre las células treg y otro grupo de células t, seleccionadas de th17, th1 y/o th2. | |
| EP2683373C0 (de) | Orthomolekulares mittel gegen die folgen von alkoholkonsum | |
| PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
| HRP20181362T1 (hr) | Kompenzacija za farmaceutsku, nutritivnu ili kozmetičku upotrebu na bazi flavonoida koja ima pojačano antioksidativno djelovanje | |
| MX2017000076A (es) | Macromoleculas estrellas compatibles con tensoactivos. | |
| AR089486A1 (es) | PREPARACION FARMACEUTICA QUE COMPRENDE b-CICLODEXTRINA SUSTITUIDA | |
| UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
| MX376262B (es) | Composiciones para el cuidado bucal con alto contenido de agua y micro resistencia. | |
| EP2968195A4 (en) | PHARMACEUTICAL FORMULATION WITH GLYCOSAMINOGLYCAN | |
| AR091349A1 (es) | Formulacion oral | |
| BR112013019924A2 (pt) | composições para cuidado oral | |
| MX381192B (es) | Una particula antimicrobiana y composiciones de la misma. | |
| CL2017000117A1 (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrófila. | |
| DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
| SMT201600471T1 (it) | Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |